Perilymph fistular diagnosis and treatment by endoscopic ear surgery

Soonchunhyang University Medical Center0 个研究点目标入组 20 人开始时间: 待定最近更新: 2023年12月19日

试验速览

暂无简介。

•? Adults aged 19 and older
•? Those who have symptoms of sensorineural hearing loss accompanied by dizziness within 3 months after barotrauma
•? Normal eardrum findings
•? Spontaneous nystagmus/positional nystagmus or positive fistula test
•? Subjects who have given written consent in the consent form

•? Those with posterior labyrinth lesions or central lesions
•? Chronic otitis media, recurrent otitis media, tympanic membrane perforation, acute inflammatory disease, conductive and sudden sensetive those diagnosed with and receiving treatment for hearing loss, objective tinnitus, or somatic tinnitus
•? Antidepressants for neuropsychiatric diseases such as depression, anxiety, sleep disorders, and convulsive disorders.
•People taking drugs that affect the neuropsychiatric system, such as anti-anxiety drugs
•? Those who have received drugs (steroids including oral/injected drugs, ototoxic drugs, etc.), surgery, or rehabilitation treatment that may affect hearing and dizziness function within 4 weeks prior to screening
•? Those in whom external ear canal surgery is not possible due to abnormal structure of the external auditory canal
•? Those who participated in another clinical (human application) test within 4 weeks prior to participating in this human application test
•? If the person does not want to, does not fill out the consent form, or is unable to understand the contents of the consent form (illiterate, foreigner, etc.)
•? In addition to the above matters, subjects who are judged by the clinical trial director to be unable to comply with the test requirements or who are deemed unsuitable by other doctors.

发起方

Soonchunhyang University Medical Center